|
|
The Constructing and Purification of Recombinant Human Fibroblast Growth Factor 8b Expressed Vector |
HUANG Peng-huang1,2,3, WANG Ze1,2,3, TIAN Hai-shan2,4, ZHAO Hai-yang2, LI Hai-yan1,3, LI Xiao-kun1,2,4 |
1. ME Engineering Research Center of Bioreactor and Pharmaceutical Development, Jilin Agriculture University, Changchun 130021, China; 2. School of Pharmacy, Wenzhou Medical College, Wenzhou 325035, China; 3. School of Life Science, Jilin Agriculture University, Changchun 130021, China; 4. Zhejiang Gelusite Biology Technology Co. Ltd., Wenzhou 325000, China |
|
|
Abstract FGF8b, which belongs to the fibroblast growth factor family, has been found to be associated with the regulation of growth and progression of hormonal cancers. Thus, it is believed that FGF8b could be a potential target in the treatment of hormonal cancers. To improve the production of recombinant hFGF8b to meet the increasing demand in basic research and clinical applications, an artificial gene encoding its mature peptide sequence was constructed and cloned into vector pET-3a. Then the recombinant proteins were expressed and presented in form of inclusion bodies in Escherichia coli BL21(DE3)pLysS. Expression, purification and renaturation conditions of the recombinant proteins were optimized. The preliminary biochemical characterization of FGF8b was further confirmed by Western blotting, and its mitogen activity was tested through MTT assay. In summary, this study has successfully acquired active recombinant FGF8b protein, which can be used for the further clinical development of embryology and the basic hormonal cancer researches.
|
Received: 18 October 2012
Published: 25 January 2013
|
|
|
|
[1] Tanaka A, Miyamoto K, Minamino N, et al. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Aead Sei USA, 1992, 89:8928-8932. [2] Gemel J, Gorry M, Ehrlich G D, et al. Structure and sequence of human FGF8. Genomics, 1996, 35(5):253-257. [3] Ornitz D M, Xu J, Colvin J S, et al. Receptor specificity of the fibroblast growth factor family. BiolChem 1996, 271(25):15292-15297. [4] Crossley P H, Martin G R. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct out growth and patterning in the developing embryo. Development, 1995, 121:439-451. [5] Sun X, Meyers E N, Lewandoski M, et al. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo.Genes Dev, 1999, 13:1834-1846. [6] Ohuchi H, Yoshioka H, Tanaka A, et al. Involvement of androgen-induced growth factor(FGF-8)gene in mouse embryogenesis and morphogenesis. Biochem Biophys ResCommun, 1994, 204(2):882-888. [7] Heikinheimo M, Lawshe A, Shackleford G M, et al. Fgf-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system. Mech Dev, 1994, 48(2):129-138. [8] Haraguchi R, Suzuki K, Murakami R, et al. Molecular analysis of external genitalia formation:the role of fibroblast growth factor(Fgf)genes during genital tubercle formation. Development, 2000, 127(11):2471-2479. [9] Crossley P H, Minowada G, MacArthur C A, et al. Roles for FGF8 in the induction, initiation, and maintenance of chick limb development. Cell, 1996, 84(1):127-136. [10] Crossley P H, Martinez S, Martin G R. Midbrain development induced by FGF8 in the chick embryo. Nature, 1996, 380(6569):66-68. [11] Daphna-Iken D, Shankar D B, Lawshe A, et al. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene, 1998, 17(21):2711-2717. [12] Zhong C, Saribekyan G, Liao C, et al. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Res, 2006, 66(4):2188-2194. [13] Dorkin T J, Robinson M C, Marsh C, et al. aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8. J Pathol, 1999, 189(4):564-569. [14] Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer, 2004, 11(4):709-724. [15] Tanaka A, Kamiakito T, Takayashiki N, et al. Fibroblast growth factor 8 expression in breast carcinoma:associations with androgen receptor and prostate-specific antigen expressions. Virchows Arch, 2002, 441(4):380-384. [16] Somboonporn W, Davis S R. Testosterone effects on the breast:implications for testosterone therapy for women. Endocr Rev, 2004, 25(3):374-388. [17] Valve E, Martikainen P, Seppanen J, et al. Expression of fibroblast growth factor(FGF)-8 isoforms and FGF receptors in human ovarian tumors. Int J Cancer, 2000, 88(5):718-725. [18] Olsen S K, Li J Y, Bromleigh C, et al. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.Genes Dev. 2006, 15;20(2):185-198. [19] Goetz R, Ohnishi M, Ding X, et al. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.Mol Cell Biol. 2012, 32(10):1944-1954. [20] Mayer M, Buchner J. Refolding of inclusion body proteins. Methods Mol Med, 2004, 94: 239-254. [21] Burgess R R. Refolding solubilized inclusion body proteins. Methods Enzymol. 2009, 463: 259-282. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|